Siroskin 0.01% Cream

0.01% Cream , Piece

4.5 (154)

890

Sirolimus 0.1% Cream is a topical medication used to treat facial angiofibromas, which are small, benign skin growths that commonly appear as red or skin-colored bumps on the face. It contains sirolimus, which works by reducing abnormal cell growth, inflammation, and the formation of new blood vessels. Regular use helps reduce the size, redness, and thickness of these lesions, improving skin appearance. Apply a thin layer to clean, dry skin as directed by your doctor. Avoid contact with the eyes, mouth, and broken or infected skin.

Description

Introduction Of Sirolimus 0.1% Cream:

Sirolimus 0.1% Cream is a medicine used to treat facial angiofibromas, which are small, benign tumors appearing as reddish or skin-colored bumps on the face. It works by reducing abnormal cell growth and inflammation.

Use Sirolimus 0.1% Cream in the dose and duration prescribed by the doctor. Clean and dry the affected area before application, then apply a thin layer of the medicine. Avoid contact with the eyes, mouth, or open wounds. Use it consistently as prescribed, and do not stop the treatment without consulting your doctor, even if you see improvement.

Inform your doctor about any other medications, creams, or skincare products you are using to avoid potential interactions. Avoid using Siroskin Cream on broken or infected skin, as it may worsen irritation. If you are pregnant, breastfeeding, or have a history of skin allergies, consult your doctor before starting this treatment. Siroskin Cream may increase skin sensitivity to sunlight, so avoid prolonged sun exposure and always use sunscreen while on treatment.

Uses Of Sirolimus 0.1% Cream:

  • Prevention of kidney transplant rejection
  • Treatment of Facial angiofibroma

Benefits Of Sirolimus 0.1% Cream:

Prevention of kidney transplant rejection In Treatment of Facial angiofibroma Facial angiofibromas are small, benign tumors that commonly appear as reddish or skin-colored bumps on the face, particularly around the nose and cheeks. Siroskin Cream inhibits abnormal cell growth and inflammation and helps treat facial angiofibroma by reducing the size, redness, and thickness of the lesions.

Mechanism Of Action Sirolimus 0.1% Cream:

Sirolimus works by inhibiting the mTOR (mammalian target of rapamycin) pathway. By blocking mTOR, sirolimus reduces abnormal cell growth, angiogenesis (formation of new blood vessels), and inflammation, which are key factors in the development of angiofibromas. This mechanism helps decrease the size, redness, and thickness of the lesions, improving their overall appearance and preventing further progression.

Contact Us

Info Table
Strength 0.1%
Pack Size 20 g
Formulation Cream
Usage Area Face
Concern Acne
Skin Type Acne Prone Skin
Shelf Life 18 months
Vendor Info
Benefits
Reviews

Description

Introduction Of Sirolimus 0.1% Cream:

Sirolimus 0.1% Cream is a medicine used to treat facial angiofibromas, which are small, benign tumors appearing as reddish or skin-colored bumps on the face. It works by reducing abnormal cell growth and inflammation.

Use Sirolimus 0.1% Cream in the dose and duration prescribed by the doctor. Clean and dry the affected area before application, then apply a thin layer of the medicine. Avoid contact with the eyes, mouth, or open wounds. Use it consistently as prescribed, and do not stop the treatment without consulting your doctor, even if you see improvement.

Inform your doctor about any other medications, creams, or skincare products you are using to avoid potential interactions. Avoid using Siroskin Cream on broken or infected skin, as it may worsen irritation. If you are pregnant, breastfeeding, or have a history of skin allergies, consult your doctor before starting this treatment. Siroskin Cream may increase skin sensitivity to sunlight, so avoid prolonged sun exposure and always use sunscreen while on treatment.

Uses Of Sirolimus 0.1% Cream:

  • Prevention of kidney transplant rejection
  • Treatment of Facial angiofibroma

Benefits Of Sirolimus 0.1% Cream:

Prevention of kidney transplant rejection In Treatment of Facial angiofibroma Facial angiofibromas are small, benign tumors that commonly appear as reddish or skin-colored bumps on the face, particularly around the nose and cheeks. Siroskin Cream inhibits abnormal cell growth and inflammation and helps treat facial angiofibroma by reducing the size, redness, and thickness of the lesions.

Mechanism Of Action Sirolimus 0.1% Cream:

Sirolimus works by inhibiting the mTOR (mammalian target of rapamycin) pathway. By blocking mTOR, sirolimus reduces abnormal cell growth, angiogenesis (formation of new blood vessels), and inflammation, which are key factors in the development of angiofibromas. This mechanism helps decrease the size, redness, and thickness of the lesions, improving their overall appearance and preventing further progression.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Siroskin 0.01% Cream”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Sirolimus 0.1% Cream used for?
Sirolimus 0.1% Cream (Siroskin) is a topical medicine used to treat facial angiofibromas — small, benign skin growths that commonly appear as red or skin-colored bumps on the face.
It inhibits the mTOR pathway, which reduces abnormal cell growth, inflammation, and the formation of new blood vessels — key factors behind angiofibroma development.
Clean and dry the affected area, then apply a thin layer as directed by your doctor. Avoid contact with the eyes, mouth, and broken or infected skin.
It can increase skin sensitivity to sunlight, so avoid prolonged sun exposure and use sunscreen during treatment. Inform your doctor if you’re pregnant, breastfeeding, or have a history of skin allergies.
Regular use over time helps reduce the size, redness, and thickness of angiofibroma lesions — consistency and following your doctor’s guidance is important for best results.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products